Skip to main content
. 2015 Sep 25;6(33):34800–34817. doi: 10.18632/oncotarget.5470

Figure 5. Suppression of hepatoma cell migration and invasion ability by CK2α silencing.

Figure 5

A, B. CK2α knockdown using specific siRNAs inhibited the migration ability of Bel-7402 (A) and HepG2 (B) cells in a Transwell migration assay. C, D. CK2α silencing using specific siRNAs remarkably attenuated the invasion ability of Bel-7402 (C) and HepG2 (D) cells in a Matrigel invasion assay. All images are shown at ×200 magnification. Data are presented as the mean ± SD of three independent experiments. P-values were calculated using the independent Student's t-test. ***P < 0.001 versus control.